1. Home
  2. EPRX vs FLL Comparison

EPRX vs FLL Comparison

Compare EPRX & FLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPRX
  • FLL
  • Stock Information
  • Founded
  • EPRX 2011
  • FLL 1987
  • Country
  • EPRX Canada
  • FLL United States
  • Employees
  • EPRX N/A
  • FLL N/A
  • Industry
  • EPRX
  • FLL Hotels/Resorts
  • Sector
  • EPRX
  • FLL Consumer Discretionary
  • Exchange
  • EPRX NYSE
  • FLL Nasdaq
  • Market Cap
  • EPRX 111.1M
  • FLL 116.4M
  • IPO Year
  • EPRX N/A
  • FLL 1993
  • Fundamental
  • Price
  • EPRX $3.85
  • FLL $3.35
  • Analyst Decision
  • EPRX Strong Buy
  • FLL Strong Buy
  • Analyst Count
  • EPRX 1
  • FLL 4
  • Target Price
  • EPRX $9.00
  • FLL $6.25
  • AVG Volume (30 Days)
  • EPRX 8.8K
  • FLL 167.3K
  • Earning Date
  • EPRX 05-07-2025
  • FLL 05-08-2025
  • Dividend Yield
  • EPRX N/A
  • FLL N/A
  • EPS Growth
  • EPRX N/A
  • FLL N/A
  • EPS
  • EPRX N/A
  • FLL N/A
  • Revenue
  • EPRX N/A
  • FLL $292,065,000.00
  • Revenue This Year
  • EPRX N/A
  • FLL $11.25
  • Revenue Next Year
  • EPRX N/A
  • FLL $8.00
  • P/E Ratio
  • EPRX N/A
  • FLL N/A
  • Revenue Growth
  • EPRX N/A
  • FLL 21.16
  • 52 Week Low
  • EPRX $2.20
  • FLL $2.91
  • 52 Week High
  • EPRX $4.48
  • FLL $5.90
  • Technical
  • Relative Strength Index (RSI)
  • EPRX N/A
  • FLL 44.85
  • Support Level
  • EPRX N/A
  • FLL $2.86
  • Resistance Level
  • EPRX N/A
  • FLL $3.06
  • Average True Range (ATR)
  • EPRX 0.00
  • FLL 0.27
  • MACD
  • EPRX 0.00
  • FLL 0.02
  • Stochastic Oscillator
  • EPRX 0.00
  • FLL 41.86

About EPRX EUPRAXIA PHARMACEUTICALS INC

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.

About FLL Full House Resorts Inc.

Full House Resorts Inc owns, operates, develops, manages, and invests in casinos and related hospitality and entertainment facilities. It offers facilities related to gaming, hotel, dining, entertainment, retail, and other amenities. The group's reportable segments are Midwest & South, West, and Contracted Sports Wagering, It generates the majority of its revenue from the Midwest & South segment which includes Silver Slipper Casino and Hotel, Rising Star Casino Resort, and American Place. The west segment includes Grand Lodge, Stockman's Casino, Bronco Billy's Casino and Hotel, and Chamonix Casino Hotel. The Contracted Sports Wagering segment comprises on-site and online sports wagering skins.

Share on Social Networks: